Cite

HARVARD Citation

    Marisi, G. et al. (n.d.). Ang-2 polymorphisms in relation to outcome in advanced HCC patients receiving sorafenib. Digestive and liver disease. 49 (1), pp. e19-. [Online]. 
  
Back to record